The close association of pi-class glutathione S-transferase with drug sensitivity to alkylating agents and cisplatin in human cancer cells.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  International Journal of Oncology

• Publication date

  1997-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.3892/IJO.10.5.1009PMID 21533477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro

  2004cited by this paper
• Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential display

  1996cited by this paper
• Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity.

  1996cited by this paper
• Transfection of glutathione S-transferase (GST)-pi antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide.

  1996cited by this paper
• Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin.

  1996cited by this paper
• Gamma-glutamylcysteine synthetase gene overexpression results in increased activity of the ATP-dependent glutathione S-conjugate export pump and cisplatin resistance.

  1995cited by this paper
• The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance.

  1995cited by this paper
• Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.

  1995cited by this paper
• Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide.

  1995cited by this paper
• Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis (*)

  1995cited by this paper
• Expression of glutathione s‐transferasepi and sensitivity of human gastric cancer cells to cisplatin

  1994cited by this paper
• Isoenzyme-specific quantitative immunoassays for cytosolic glutathione transferases and measurement of the enzymes in blood plasma from cancer patients and in tumor cell lines.

  1994cited by this paper
• Glutathione-associated enzymes in anticancer drug resistance.

  1994cited by this paper
• Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair.

  1994cited by this paper
• Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells.

  1993cited by this paper
• A newly synthesized bifunctional inhibitor, W-77, enhances adriamycin activity against human ovarian carcinoma cells.

  1993cited by this paper
• Glutathione S-transferase pi levels in a panel of lung cancer cell lines and its relation to chemo-radiosensitivity.

  1993cited by this paper
• Significance of glutathione S‐transferase‐π as a tumor marker in patients with oral cancer

  1992cited by this paper
• High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.

  1992cited by this paper
• Regulation of human glutathione S-transferase pi gene transcription: influence of 5'-flanking sequences and trans-activating factors which recognize AP-1-binding sites.

  1990cited by this paper
• Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene.

  1990cited by this paper
• Glutathione-S-transferase pi as a determinant of drug resistance in transfectant cell lines.

  1990cited by this paper
• Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients.

  1990cited by this paper
• Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione.

  1989cited by this paper
• Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line.

  1989cited by this paper
• Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines.

  1988cited by this paper
• Structure and expression of a human class pi glutathione S-transferase messenger RNA.

  1987cited by this paper
• Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity.

  1987cited by this paper
• Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).

  1987cited by this paper
• Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

  1987cited by this paper
• Conversion of melphalan to 4-(glutathionyl)phenylalanine. A novel mechanism for conjugation by glutathione-S-transferases.

  1987cited by this paper
• Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions.

  1987cited by this paper
• Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.

  1987cited by this paper
• Similar biochemical changes associated with multidrug resistance in human breast cancer cells and carcinogen-induced resistance to xenobiotics in rats.

  1986cited by this paper
• Role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation.

  1985cited by this paper
• Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine.

  1985cited by this paper
• Reduction in cellular glutathione by buthionine sulfoximine and sensitization of murine tumor cells resistant to L-phenylalanine mustard.

  1984cited by this paper
• Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

  1984cited by this paper
• Glutathione metabolism as a determinant of therapeutic efficacy: a review.

  1984cited by this paper
• Glutathione.

  1983cited by this paper
• Reduction in glutathione content of L-PAM resistant L1210 Cells confers drug sensitivity.

  1982cited by this paper
• Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible chemotherapeutic implications.

  1979cited by this paper

• Maturation of cochlear glutathione-S-transferases correlates with the end of the sensitive period for ototoxicity.

  1999cites this paper
• Cellular balance of glutathione levels through the expression of gamma-glutamylcysteine synthetase and glutathione thiol transferase genes in human hepatic cells resistant to a glutathione poison.

  1999cites this paper
• Glutathione homeostasis in human hepatic cells: overexpression of gamma-glutamylcysteine synthetase gene in cell lines resistant to buthionine sulfoximine, an inhibitor of glutathione synthesis.

  1998cites this paper